Sameh Daher

551 total citations
15 papers, 374 citations indexed

About

Sameh Daher is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Sameh Daher has authored 15 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Sameh Daher's work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Sameh Daher is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Sameh Daher collaborates with scholars based in Israel, United States and Poland. Sameh Daher's co-authors include Jair Bar, Damien Urban, Elizabeth Dudnik, Teodor Gottfried, Amir Onn, Gal Markel, Mira Wollner, Tzippy Shochat, Mor Moskovitz and Alona Zer and has published in prestigious journals such as Scientific Reports, American Journal of Physiology-Heart and Circulatory Physiology and European Journal of Cancer.

In The Last Decade

Sameh Daher

13 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sameh Daher Israel	10	294	155	49	43	40	15	374
Yingjian Song China	10	192 0.7×	133 0.9×	32 0.7×	9 0.2×	46 1.1×	16	373
Wataru Shioyama Japan	10	89 0.3×	145 0.9×	13 0.3×	149 3.5×	46 1.1×	36	316
Hiroshi Nakade Japan	13	245 0.8×	207 1.3×	24 0.5×	19 0.4×	233 5.8×	31	456
Hui-Wen Weng China	9	122 0.4×	133 0.9×	10 0.2×	15 0.3×	45 1.1×	14	371
Karlijn L. van Rooijen Netherlands	6	142 0.5×	75 0.5×	23 0.5×	8 0.2×	38 0.9×	10	247
D. Carmier France	9	81 0.3×	227 1.5×	21 0.4×	17 0.4×	19 0.5×	18	351
Shuling Han China	8	183 0.6×	48 0.3×	110 2.2×	14 0.3×	50 1.3×	28	346
G. Mantovani Italy	9	151 0.5×	38 0.2×	18 0.4×	53 1.2×	125 3.1×	27	291
Zi‐Niu Ding China	11	179 0.6×	70 0.5×	68 1.4×	14 0.3×	38 0.9×	45	391
Takahito Taniura Japan	12	246 0.8×	160 1.0×	27 0.6×	9 0.2×	163 4.1×	25	403

Countries citing papers authored by Sameh Daher

Since Specialization

Citations

This map shows the geographic impact of Sameh Daher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameh Daher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameh Daher more than expected).

Fields of papers citing papers by Sameh Daher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sameh Daher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameh Daher. The network helps show where Sameh Daher may publish in the future.

Co-authorship network of co-authors of Sameh Daher

This figure shows the co-authorship network connecting the top 25 collaborators of Sameh Daher. A scholar is included among the top collaborators of Sameh Daher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sameh Daher. Sameh Daher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Shalata, Walid, Waleed Kian, Rafał Dziadziuszko, et al.. (2024). Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study). Current Oncology. 31(8). 4369–4381. 1 indexed citations

Shalata, Walid, Sameh Daher, Sivan Shamai, et al.. (2024). Real-World Clinical Outcomes of Neoadjuvant Platinum-Based Chemotherapy with Nivolumab in Non-Small Cell Lung Cancer. Journal of Clinical Medicine. 13(21). 6568–6568.

Haberman, Yael, Iris Kamer, Amnon Amir, et al.. (2023). Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit. Scientific Reports. 13(1). 2007–2007. 12 indexed citations

Daher, Sameh, Alona Zer, Roi Tschernichovsky, et al.. (2023). Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer. Lung Cancer. 178. 229–236. 14 indexed citations

Goldstein, Jeffrey, Sarit Appel, Sameh Daher, et al.. (2022). Chemoradiation followed by adjuvant durvalumab in stage III non–small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradiation alone. Thoracic Cancer. 13(12). 1763–1771. 14 indexed citations

Moskovitz, Mor, Damien Urban, Hovav Nechushtan, et al.. (2021). dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50%. Clinical Lung Cancer. 23(2). 122–134. 17 indexed citations

Daher, Sameh, Yaacov Richard Lawrence, Elizabeth Dudnik, et al.. (2021). Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers. Frontiers in Oncology. 11. 625668–625668. 9 indexed citations

Onn, Amir, Teodor Gottfried, Amos Stemmer, et al.. (2021). Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung Cancer. Cancers. 13(11). 2800–2800. 5 indexed citations

Dudnik, Elizabeth, Mor Moskovitz, Yakir Rottenberg, et al.. (2021). Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data. OncoImmunology. 10(1). 1865653–1865653. 33 indexed citations

10.

Magri, Valentina, Teodor Gottfried, Mattia Di Segni, et al.. (2019). <p>Correlation of body composition by computerized tomography and metabolic parameters with survival of nivolumab-treated lung cancer patients</p>. Cancer Management and Research. Volume 11. 8201–8207. 39 indexed citations

11.

Bar, Jair, Gal Markel, Teodor Gottfried, et al.. (2019). Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study. European Journal of Cancer. 120. 122–131. 84 indexed citations

12.

Eshet, Yael, Erez N. Baruch, Ronnie Shapira‐Frommer, et al.. (2018). Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case–Control Study. Cancer Immunology Research. 6(12). 1453–1458. 46 indexed citations

13.

Daher, Sameh & Jair Bar. (2018). Targeting angiogenesis in lung cancer. memo - Magazine of European Medical Oncology. 11(1). 9–13. 2 indexed citations

14.

Dudnik, Elizabeth, Mor Moskovitz, Sameh Daher, et al.. (2017). Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data. Lung Cancer. 126. 217–223. 80 indexed citations

15.

Shuvy, Mony, Suzan Abedat, Rоnen Beeri, et al.. (2011). Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure. American Journal of Physiology-Heart and Circulatory Physiology. 300(5). H1829–H1840. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact